These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 27255748)

  • 1. Influenza virus neuraminidase (NA): a target for antivirals and vaccines.
    Jagadesh A; Salam AA; Mudgal PP; Arunkumar G
    Arch Virol; 2016 Aug; 161(8):2087-94. PubMed ID: 27255748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines.
    Marcelin G; Sandbulte MR; Webby RJ
    Rev Med Virol; 2012 Jul; 22(4):267-79. PubMed ID: 22438243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection abilities of influenza B virus DNA vaccines expressing hemagglutinin, neuraminidase, or both in mice.
    Fang F; Cai XQ; Chang HY; Wang HD; Yang ZD; Chen Z
    Acta Virol; 2008; 52(2):107-12. PubMed ID: 18564897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Recombinant Influenza Virus Neuraminidase Vaccine Candidate Stabilized by a Measles Virus Phosphoprotein Tetramerization Domain Provides Robust Protection from Virus Challenge in the Mouse Model.
    Strohmeier S; Amanat F; Zhu X; McMahon M; Deming ME; Pasetti MF; Neuzil KM; Wilson IA; Krammer F
    mBio; 2021 Dec; 12(6):e0224121. PubMed ID: 34809451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lactococcus lactis displayed neuraminidase confers cross protective immunity against influenza A viruses in mice.
    Lei H; Peng X; Zhao D; Ouyang J; Jiao H; Shu H; Ge X
    Virology; 2015 Feb; 476():189-195. PubMed ID: 25546254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on immunogenicity of a recombinant adenovirus vaccine containing neuraminidase gene of H5N1 influenza virus (A/Anhui/1/2005) in mice].
    Ma J; Zhang XG; Li KB; Zhang XM; Wang M; Bai T; Yang L; Xu H; Shu YL; Zeng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Dec; 23(6):449-51. PubMed ID: 20718353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza Neuraminidase Characteristics and Potential as a Vaccine Target.
    Creytens S; Pascha MN; Ballegeer M; Saelens X; de Haan CAM
    Front Immunol; 2021; 12():786617. PubMed ID: 34868073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuraminidase, the Forgotten Surface Antigen, Emerges as an Influenza Vaccine Target for Broadened Protection.
    Eichelberger MC; Monto AS
    J Infect Dis; 2019 Apr; 219(Suppl_1):S75-S80. PubMed ID: 30715357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response.
    Johansson BE; Matthews JT; Kilbourne ED
    Vaccine; 1998; 16(9-10):1009-15. PubMed ID: 9682352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Universal influenza vaccines: developments, prospects for use].
    Tsybalova LM; Kiselev OI
    Vopr Virusol; 2012; 57(1):9-14. PubMed ID: 22624467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
    Ryder AB; Buonocore L; Vogel L; Nachbagauer R; Krammer F; Rose JK
    J Virol; 2015 Mar; 89(5):2820-30. PubMed ID: 25540378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing perspective on immunization against influenza.
    Johansson BE; Brett IC
    Vaccine; 2007 Apr; 25(16):3062-5. PubMed ID: 17276554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and protective properties of immune sera directed to the influenza virus neuraminidase.
    Halbherr SJ; Ludersdorfer TH; Ricklin M; Locher S; Berger Rentsch M; Summerfield A; Zimmer G
    J Virol; 2015 Feb; 89(3):1550-63. PubMed ID: 25392225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen.
    Wohlbold TJ; Krammer F
    Viruses; 2014 Jun; 6(6):2465-94. PubMed ID: 24960271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition.
    Johansson BE; Kilbourne ED
    Virology; 1996 Nov; 225(1):136-44. PubMed ID: 8918540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of antibodies to influenza A virus hemagglutinin, neuraminidase, and M2e in conferring cross protection.
    Kim YJ; Ko EJ; Kim MC; Lee YN; Kim KH; Jung YJ; Kang SM
    Biochem Biophys Res Commun; 2017 Nov; 493(1):393-398. PubMed ID: 28887040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A DNA vaccine expressing PB1 protein of influenza A virus protects mice against virus infection.
    Košík I; Krejnusová I; Práznovská M; Poláková K; Russ G
    Arch Virol; 2012 May; 157(5):811-7. PubMed ID: 22294447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influenza viral neuraminidase: the forgotten antigen.
    Johansson BE; Cox MM
    Expert Rev Vaccines; 2011 Dec; 10(12):1683-95. PubMed ID: 22085172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system.
    Brett IC; Johansson BE
    Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of influenza vaccine strain A/Vietnam/1194/2004 (H5N1) growth with the neuraminidase packaging sequence from A/Puerto Rico/8/34.
    Pan W; Dong Z; Meng W; Zhang W; Li T; Li C; Zhang B; Chen L
    Hum Vaccin Immunother; 2012 Feb; 8(2):252-9. PubMed ID: 22426370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.